South & Central America Embolization Devices Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The embolization devices market in South and Central America is projected to grow significantly, reaching approximately US$ 352.84 million by 2031, up from US$ 192.82 million in 2024. This growth represents a compound annual growth rate (CAGR) of 9.1% from 2025 to 2031.

Executive Summary and Market Analysis

The market is divided into key regions: Brazil, Argentina, and the Rest of South and Central America. The region is poised for growth due to an increase in various health conditions, advancements in healthcare systems, and heightened awareness of chronic diseases. Additionally, the rise in unhealthy lifestyle choices among the population is leading to a greater incidence of diseases, thereby increasing the demand for embolization devices. Government initiatives aimed at improving healthcare are also expected to propel market growth. The aging population and rising healthcare expenditures further contribute to the demand for advanced medical treatments. Countries like Brazil and Mexico are enhancing their healthcare infrastructure and attracting foreign investments, which facilitates the adoption of innovative medical technologies.

Market Segmentation Analysis

The South and Central America embolization devices market is categorized by type, application, and end user.

By Type: The market includes embolization coils, plugs, beads, glues, and other devices. In 2024, embolization coils dominated the market share, with further segmentation into central and peripheral applications.
By Application: The market is segmented into neurology, peripheral vascular disease, oncology, urology, and others, with neurology holding the largest market share in 2024.
By End User: The end users are classified into hospitals, ambulatory centers, and others, with hospitals accounting for the largest share in 2024.

Market Outlook

Innovations in embolization devices, such as enhanced catheter designs, new embolic agents, and detachable coils, have improved the safety and effectiveness of embolization procedures. For instance, flow-diverting devices have transformed the treatment of complex intracranial aneurysms by redirecting blood flow away from the aneurysm, promoting thrombosis within the sac. Clinical studies play a crucial role in advancing these techniques, leading to broader applications and better patient outcomes. The IMPASS embolic coil device, developed by Fluidx Medical Technology, has shown promise in treating chronic subdural hematomas by targeting the middle meningeal artery, as evidenced by recent in-vivo studies.

The Caterpillar Arterial Embolization System, assessed in a first-in-human study, demonstrated successful occlusion in peripheral arteries with minimal risk of serious adverse events. This device, featuring opposing nitinol fibers and a flow-occluding membrane, aims to simplify the embolization process across various vessel sizes.

As the market evolves, the collaboration between clinical research and device innovation will be essential in meeting the increasing demand for effective embolization therapies. Integrating clinical studies into the development of these devices is becoming a significant trend, leading to advancements in treatment options and improved patient outcomes.

Country Insights

The South and Central America embolization devices market includes Brazil, Argentina, and other regions, with Brazil holding the largest market share in 2024. Trauma is a leading cause of death in Brazil, particularly among individuals aged 1-39, with embolization procedures being critical for controlling bleeding from injuries. The prevalence of abdominal aortic aneurysms, especially in individuals over 60, further underscores the importance of these procedures. The aging population in Brazil is expected to grow significantly, with projections indicating that by 2031, nearly 50 million people will be aged 60 and above, representing 24% of the population. This demographic shift highlights the increasing relevance of embolization procedures, which are favored for their minimally invasive nature and shorter recovery times compared to traditional surgeries.

Company Profiles

Key players in the embolization devices market include Medtronic Plc, Cook Medical Holdings LLC, Stryker Corp, Boston Scientific Corp, Terumo Corp, Johnson & Johnson, Abbott Laboratories, and others. These companies are pursuing strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America embolization devices market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in South & Central America embolization devices market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the embolization devices market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution. Show more